Global Viral Vector-Based Gene Therapy Market Growth (Status and Outlook) 2022-2028
The global market for Viral Vector-Based Gene Therapy is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Viral Vector-Based Gene Therapy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Viral Vector-Based Gene Therapy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Viral Vector-Based Gene Therapy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Viral Vector-Based Gene Therapy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Viral Vector-Based Gene Therapy players cover Sibiono, Rigvir Group, Shanghai Pharma (Sunway), Amgen and Spark Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Viral Vector-Based Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Viral Vector-Based Gene Therapy market, with both quantitative and qualitative data, to help readers understand how the Viral Vector-Based Gene Therapy market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Viral Vector-Based Gene Therapy market and forecasts the market size by Type (Adenovirus (AdV) and Adeno-associated Virus (AAV),), by Application (Hospital, Clinic and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Adenovirus (AdV)
Adeno-associated Virus (AAV)
Segmentation by application
Hospital
Clinic
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Sibiono
Rigvir Group
Shanghai Pharma (Sunway)
Amgen
Spark Therapeutics
Novartis Gene Therapies
Daiichi Sankyo
PTC Therapeutics
Chapter Introduction
Chapter 1: Scope of Viral Vector-Based Gene Therapy, Research Methodology, etc.
Chapter 2: Executive Summary, global Viral Vector-Based Gene Therapy market size and CAGR, Viral Vector-Based Gene Therapy market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Viral Vector-Based Gene Therapy revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Viral Vector-Based Gene Therapy revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Viral Vector-Based Gene Therapy market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Sibiono, Rigvir Group, Shanghai Pharma (Sunway), Amgen, Spark Therapeutics, Novartis Gene Therapies, Daiichi Sankyo and PTC Therapeutics, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Viral Vector-Based Gene Therapy Market Size 2017-2028
2.1.2 Viral Vector-Based Gene Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Viral Vector-Based Gene Therapy Segment by Type
2.2.1 Adenovirus (AdV)
2.2.2 Adeno-associated Virus (AAV)
2.3 Viral Vector-Based Gene Therapy Market Size by Type
2.3.1 Viral Vector-Based Gene Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Viral Vector-Based Gene Therapy Market Size Market Share by Type (2017-2022)
2.4 Viral Vector-Based Gene Therapy Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Viral Vector-Based Gene Therapy Market Size by Application
2.5.1 Viral Vector-Based Gene Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Viral Vector-Based Gene Therapy Market Size Market Share by Application (2017-2022)
3 Viral Vector-Based Gene Therapy Market Size by Player
3.1 Viral Vector-Based Gene Therapy Market Size Market Share by Players
3.1.1 Global Viral Vector-Based Gene Therapy Revenue by Players (2020-2022)
3.1.2 Global Viral Vector-Based Gene Therapy Revenue Market Share by Players (2020-2022)
3.2 Global Viral Vector-Based Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Viral Vector-Based Gene Therapy by Regions
4.1 Viral Vector-Based Gene Therapy Market Size by Regions (2017-2022)
4.2 Americas Viral Vector-Based Gene Therapy Market Size Growth (2017-2022)
4.3 APAC Viral Vector-Based Gene Therapy Market Size Growth (2017-2022)
4.4 Europe Viral Vector-Based Gene Therapy Market Size Growth (2017-2022)
4.5 Middle East & Africa Viral Vector-Based Gene Therapy Market Size Growth (2017-2022)
5 Americas
5.1 Americas Viral Vector-Based Gene Therapy Market Size by Country (2017-2022)
5.2 Americas Viral Vector-Based Gene Therapy Market Size by Type (2017-2022)
5.3 Americas Viral Vector-Based Gene Therapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viral Vector-Based Gene Therapy Market Size by Region (2017-2022)
6.2 APAC Viral Vector-Based Gene Therapy Market Size by Type (2017-2022)
6.3 APAC Viral Vector-Based Gene Therapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Viral Vector-Based Gene Therapy by Country (2017-2022)
7.2 Europe Viral Vector-Based Gene Therapy Market Size by Type (2017-2022)
7.3 Europe Viral Vector-Based Gene Therapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Viral Vector-Based Gene Therapy by Region (2017-2022)
8.2 Middle East & Africa Viral Vector-Based Gene Therapy Market Size by Type (2017-2022)
8.3 Middle East & Africa Viral Vector-Based Gene Therapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Viral Vector-Based Gene Therapy Market Forecast
10.1 Global Viral Vector-Based Gene Therapy Forecast by Regions (2023-2028)
10.1.1 Global Viral Vector-Based Gene Therapy Forecast by Regions (2023-2028)
10.1.2 Americas Viral Vector-Based Gene Therapy Forecast
10.1.3 APAC Viral Vector-Based Gene Therapy Forecast
10.1.4 Europe Viral Vector-Based Gene Therapy Forecast
10.1.5 Middle East & Africa Viral Vector-Based Gene Therapy Forecast
10.2 Americas Viral Vector-Based Gene Therapy Forecast by Country (2023-2028)
10.2.1 United States Viral Vector-Based Gene Therapy Market Forecast
10.2.2 Canada Viral Vector-Based Gene Therapy Market Forecast
10.2.3 Mexico Viral Vector-Based Gene Therapy Market Forecast
10.2.4 Brazil Viral Vector-Based Gene Therapy Market Forecast
10.3 APAC Viral Vector-Based Gene Therapy Forecast by Region (2023-2028)
10.3.1 China Viral Vector-Based Gene Therapy Market Forecast
10.3.2 Japan Viral Vector-Based Gene Therapy Market Forecast
10.3.3 Korea Viral Vector-Based Gene Therapy Market Forecast
10.3.4 Southeast Asia Viral Vector-Based Gene Therapy Market Forecast
10.3.5 India Viral Vector-Based Gene Therapy Market Forecast
10.3.6 Australia Viral Vector-Based Gene Therapy Market Forecast
10.4 Europe Viral Vector-Based Gene Therapy Forecast by Country (2023-2028)
10.4.1 Germany Viral Vector-Based Gene Therapy Market Forecast
10.4.2 France Viral Vector-Based Gene Therapy Market Forecast
10.4.3 UK Viral Vector-Based Gene Therapy Market Forecast
10.4.4 Italy Viral Vector-Based Gene Therapy Market Forecast
10.4.5 Russia Viral Vector-Based Gene Therapy Market Forecast
10.5 Middle East & Africa Viral Vector-Based Gene Therapy Forecast by Region (2023-2028)
10.5.1 Egypt Viral Vector-Based Gene Therapy Market Forecast
10.5.2 South Africa Viral Vector-Based Gene Therapy Market Forecast
10.5.3 Israel Viral Vector-Based Gene Therapy Market Forecast
10.5.4 Turkey Viral Vector-Based Gene Therapy Market Forecast
10.5.5 GCC Countries Viral Vector-Based Gene Therapy Market Forecast
10.6 Global Viral Vector-Based Gene Therapy Forecast by Type (2023-2028)
10.7 Global Viral Vector-Based Gene Therapy Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sibiono
11.1.1 Sibiono Company Information
11.1.2 Sibiono Viral Vector-Based Gene Therapy Product Offered
11.1.3 Sibiono Viral Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sibiono Main Business Overview
11.1.5 Sibiono Latest Developments
11.2 Rigvir Group
11.2.1 Rigvir Group Company Information
11.2.2 Rigvir Group Viral Vector-Based Gene Therapy Product Offered
11.2.3 Rigvir Group Viral Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Rigvir Group Main Business Overview
11.2.5 Rigvir Group Latest Developments
11.3 Shanghai Pharma (Sunway)
11.3.1 Shanghai Pharma (Sunway) Company Information
11.3.2 Shanghai Pharma (Sunway) Viral Vector-Based Gene Therapy Product Offered
11.3.3 Shanghai Pharma (Sunway) Viral Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Shanghai Pharma (Sunway) Main Business Overview
11.3.5 Shanghai Pharma (Sunway) Latest Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen Viral Vector-Based Gene Therapy Product Offered
11.4.3 Amgen Viral Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Amgen Main Business Overview
11.4.5 Amgen Latest Developments
11.5 Spark Therapeutics
11.5.1 Spark Therapeutics Company Information
11.5.2 Spark Therapeutics Viral Vector-Based Gene Therapy Product Offered
11.5.3 Spark Therapeutics Viral Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Spark Therapeutics Main Business Overview
11.5.5 Spark Therapeutics Latest Developments
11.6 Novartis Gene Therapies
11.6.1 Novartis Gene Therapies Company Information
11.6.2 Novartis Gene Therapies Viral Vector-Based Gene Therapy Product Offered
11.6.3 Novartis Gene Therapies Viral Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Novartis Gene Therapies Main Business Overview
11.6.5 Novartis Gene Therapies Latest Developments
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Information
11.7.2 Daiichi Sankyo Viral Vector-Based Gene Therapy Product Offered
11.7.3 Daiichi Sankyo Viral Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Daiichi Sankyo Main Business Overview
11.7.5 Daiichi Sankyo Latest Developments
11.8 PTC Therapeutics
11.8.1 PTC Therapeutics Company Information
11.8.2 PTC Therapeutics Viral Vector-Based Gene Therapy Product Offered
11.8.3 PTC Therapeutics Viral Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 PTC Therapeutics Main Business Overview
11.8.5 PTC Therapeutics Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Viral Vector-Based Gene Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Adenovirus (AdV)
Table 3. Major Players of Adeno-associated Virus (AAV)
Table 4. Viral Vector-Based Gene Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Viral Vector-Based Gene Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Viral Vector-Based Gene Therapy Market Size Market Share by Type (2017-2022)
Table 7. Viral Vector-Based Gene Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Viral Vector-Based Gene Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Viral Vector-Based Gene Therapy Market Size Market Share by Application (2017-2022)
Table 10. Global Viral Vector-Based Gene Therapy Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Viral Vector-Based Gene Therapy Revenue Market Share by Player (2020-2022)
Table 12. Viral Vector-Based Gene Therapy Key Players Head office and Products Offered
Table 13. Viral Vector-Based Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Viral Vector-Based Gene Therapy Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Viral Vector-Based Gene Therapy Market Size Market Share by Regions (2017-2022)
Table 18. Americas Viral Vector-Based Gene Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Viral Vector-Based Gene Therapy Market Size Market Share by Country (2017-2022)
Table 20. Americas Viral Vector-Based Gene Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Viral Vector-Based Gene Therapy Market Size Market Share by Type (2017-2022)
Table 22. Americas Viral Vector-Based Gene Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Viral Vector-Based Gene Therapy Market Size Market Share by Application (2017-2022)
Table 24. APAC Viral Vector-Based Gene Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Viral Vector-Based Gene Therapy Market Size Market Share by Region (2017-2022)
Table 26. APAC Viral Vector-Based Gene Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Viral Vector-Based Gene Therapy Market Size Market Share by Type (2017-2022)
Table 28. APAC Viral Vector-Based Gene Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Viral Vector-Based Gene Therapy Market Size Market Share by Application (2017-2022)
Table 30. Europe Viral Vector-Based Gene Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Viral Vector-Based Gene Therapy Market Size Market Share by Country (2017-2022)
Table 32. Europe Viral Vector-Based Gene Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Viral Vector-Based Gene Therapy Market Size Market Share by Type (2017-2022)
Table 34. Europe Viral Vector-Based Gene Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Viral Vector-Based Gene Therapy Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Viral Vector-Based Gene Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Viral Vector-Based Gene Therapy Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Viral Vector-Based Gene Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Viral Vector-Based Gene Therapy Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Viral Vector-Based Gene Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Viral Vector-Based Gene Therapy Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Viral Vector-Based Gene Therapy
Table 43. Key Market Challenges & Risks of Viral Vector-Based Gene Therapy
Table 44. Key Industry Trends of Viral Vector-Based Gene Therapy
Table 45. Global Viral Vector-Based Gene Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Viral Vector-Based Gene Therapy Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Viral Vector-Based Gene Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Viral Vector-Based Gene Therapy Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Viral Vector-Based Gene Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Viral Vector-Based Gene Therapy Market Size Market Share Forecast by Application (2023-2028)
Table 51. Sibiono Details, Company Type, Viral Vector-Based Gene Therapy Area Served and Its Competitors
Table 52. Sibiono Viral Vector-Based Gene Therapy Product Offered
Table 53. Sibiono Viral Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Sibiono Main Business
Table 55. Sibiono Latest Developments
Table 56. Rigvir Group Details, Company Type, Viral Vector-Based Gene Therapy Area Served and Its Competitors
Table 57. Rigvir Group Viral Vector-Based Gene Therapy Product Offered
Table 58. Rigvir Group Main Business
Table 59. Rigvir Group Viral Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Rigvir Group Latest Developments
Table 61. Shanghai Pharma (Sunway) Details, Company Type, Viral Vector-Based Gene Therapy Area Served and Its Competitors
Table 62. Shanghai Pharma (Sunway) Viral Vector-Based Gene Therapy Product Offered
Table 63. Shanghai Pharma (Sunway) Main Business
Table 64. Shanghai Pharma (Sunway) Viral Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Shanghai Pharma (Sunway) Latest Developments
Table 66. Amgen Details, Company Type, Viral Vector-Based Gene Therapy Area Served and Its Competitors
Table 67. Amgen Viral Vector-Based Gene Therapy Product Offered
Table 68. Amgen Main Business
Table 69. Amgen Viral Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Amgen Latest Developments
Table 71. Spark Therapeutics Details, Company Type, Viral Vector-Based Gene Therapy Area Served and Its Competitors
Table 72. Spark Therapeutics Viral Vector-Based Gene Therapy Product Offered
Table 73. Spark Therapeutics Main Business
Table 74. Spark Therapeutics Viral Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Spark Therapeutics Latest Developments
Table 76. Novartis Gene Therapies Details, Company Type, Viral Vector-Based Gene Therapy Area Served and Its Competitors
Table 77. Novartis Gene Therapies Viral Vector-Based Gene Therapy Product Offered
Table 78. Novartis Gene Therapies Main Business
Table 79. Novartis Gene Therapies Viral Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Novartis Gene Therapies Latest Developments
Table 81. Daiichi Sankyo Details, Company Type, Viral Vector-Based Gene Therapy Area Served and Its Competitors
Table 82. Daiichi Sankyo Viral Vector-Based Gene Therapy Product Offered
Table 83. Daiichi Sankyo Main Business
Table 84. Daiichi Sankyo Viral Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Daiichi Sankyo Latest Developments
Table 86. PTC Therapeutics Details, Company Type, Viral Vector-Based Gene Therapy Area Served and Its Competitors
Table 87. PTC Therapeutics Viral Vector-Based Gene Therapy Product Offered
Table 88. PTC Therapeutics Main Business
Table 89. PTC Therapeutics Viral Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. PTC Therapeutics Latest Developments
List of Figures
List of Figures
Figure 1. Viral Vector-Based Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Viral Vector-Based Gene Therapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Viral Vector-Based Gene Therapy Market Size Market Share by Type in 2021
Figure 7. Viral Vector-Based Gene Therapy in Hospital
Figure 8. Global Viral Vector-Based Gene Therapy Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Viral Vector-Based Gene Therapy in Clinic
Figure 10. Global Viral Vector-Based Gene Therapy Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Viral Vector-Based Gene Therapy in Others
Figure 12. Global Viral Vector-Based Gene Therapy Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Viral Vector-Based Gene Therapy Market Size Market Share by Application in 2021
Figure 14. Global Viral Vector-Based Gene Therapy Revenue Market Share by Player in 2021
Figure 15. Global Viral Vector-Based Gene Therapy Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Viral Vector-Based Gene Therapy Market Size 2017-2022 ($ Millions)
Figure 17. APAC Viral Vector-Based Gene Therapy Market Size 2017-2022 ($ Millions)
Figure 18. Europe Viral Vector-Based Gene Therapy Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Viral Vector-Based Gene Therapy Market Size 2017-2022 ($ Millions)
Figure 20. Americas Viral Vector-Based Gene Therapy Value Market Share by Country in 2021
Figure 21. Americas Viral Vector-Based Gene Therapy Consumption Market Share by Type in 2021
Figure 22. Americas Viral Vector-Based Gene Therapy Market Size Market Share by Application in 2021
Figure 23. United States Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Viral Vector-Based Gene Therapy Market Size Market Share by Region in 2021
Figure 28. APAC Viral Vector-Based Gene Therapy Market Size Market Share by Application in 2021
Figure 29. China Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Viral Vector-Based Gene Therapy Market Size Market Share by Country in 2021
Figure 36. Europe Viral Vector-Based Gene Therapy Market Size Market Share by Type in 2021
Figure 37. Europe Viral Vector-Based Gene Therapy Market Size Market Share by Application in 2021
Figure 38. Germany Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Viral Vector-Based Gene Therapy Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Viral Vector-Based Gene Therapy Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Viral Vector-Based Gene Therapy Market Size Market Share by Application in 2021
Figure 46. Egypt Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Viral Vector-Based Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 52. APAC Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 53. Europe Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 55. United States Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 56. Canada Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 59. China Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 60. Japan Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 61. Korea Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 63. India Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 64. Australia Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 65. Germany Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 66. France Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 67. UK Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 68. Italy Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 69. Russia Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 70. Spain Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 73. Israel Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Viral Vector-Based Gene Therapy Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets